Last reviewed · How we verify
JZoloft
At a glance
| Generic name | JZoloft |
|---|---|
| Also known as | sertraline hydrochloride |
| Sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Drug Use Investigation of Jzoloft.
- A Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic Disorder (PHASE4)
- Bioequivalence Of Zoloft ODT To Jzoloft In Healthy Japanese Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- JZoloft CI brief — competitive landscape report
- JZoloft updates RSS · CI watch RSS
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. portfolio CI